阜阳在线's Archiver

论坛首页 › 精华专区 › 重磅 弱视双眼追踪数字疗法!

网站小七 发表于 2025-6-16 13:58

重磅 弱视双眼追踪数字疗法!

<!----><style type="text/css">html{font-size:375%}</style><link href="https://pic.app.fy169.net/frontend/web/static/publish/css/style.css?v=20240712" rel="stylesheet" position="1" data-qf-origin="/frontend/web/static/publish/css/style.css?v=20240712"><!--    付费贴-->    <div class="preview_article ">            <!---->    <section style="text-align: right; margin: 0px 0px 10px; line-height: 0; box-sizing: border-box;"></section><section style="text-align: right; margin: 0px 0px 10px; line-height: 0; box-sizing: border-box;"></section><section style="text-align: right; margin: 0px 0px 10px; line-height: 0; box-sizing: border-box;"><section style="max-width: 100%; vertical-align: middle; display: inline-block; line-height: 0; width: 30%; height: auto; box-sizing: border-box;"><img class="rich_pages wxw-img" style="vertical-align: middle; max-width: 100%; width: 203.094px !important; box-sizing: border-box; height: auto !important; visibility: visible !important;" src="https://pic.app.fy169.net/FhkJUtYPmHyLJ9taHtB0cUA4vtbO" alt="图片" /></section></section><section style="display: flex; width: 100%; flex-flow: column; box-sizing: border-box;"><section style="z-index: 3; box-sizing: border-box;"><section style="text-align: center; justify-content: center; display: flex; flex-flow: row; margin: -75px 0px 0px; box-sizing: border-box;"><section style="display: inline-block; width: 90%; vertical-align: top; align-self: flex-start; flex: 0 0 auto; background-color: #ffffff; height: auto; border-bottom: 1px solid #375eb5; border-top-left-radius: 8px; border-top-right-radius: 8px; overflow: hidden; box-sizing: border-box;"><section style="text-align: left; margin: 0px 0px 10px; line-height: 0; box-sizing: border-box;"><section style="max-width: 100%; vertical-align: middle; display: inline-block; line-height: 0; width: 79.2656px; height: auto; box-sizing: border-box;"><img class="rich_pages wxw-img" style="vertical-align: middle; max-width: 100%; width: 79.2578px !important; height: auto !important; box-sizing: border-box; visibility: visible !important; pointer-events: none;" src="https://pic.app.fy169.net/FkkPVji7Vd1yUNljUbLZiAXVs7Mi" alt="图片" /></section></section><section style="justify-content: center; display: flex; flex-flow: row; margin: -50px 0px 0px; box-sizing: border-box;"><section style="display: inline-block; vertical-align: middle; width: auto; align-self: center; flex: 0 0 auto; background-color: #f4d997; min-width: 5%; max-width: 100%; height: auto; border-radius: 5px; overflow: hidden; box-sizing: border-box;"></section><section style="display: inline-block; vertical-align: middle; width: auto; align-self: center; flex: 0 0 auto; min-width: 5%; max-width: 100%; height: auto; padding: 0px 0px 0px 10px; box-sizing: border-box;"><section style="display: flex; width: 100%; flex-flow: column; box-sizing: border-box;"><section style="z-index: 3; box-sizing: border-box;"><section style="text-align: justify; font-size: 18px; color: #375eb5; padding: 0px 25px; box-sizing: border-box;"><p><span style="mso-spacerun: yes; font-family: 微软雅黑; font-size: 10.5000pt; mso-font-kerning: 0.0000pt;"><span style="font-family: 微软雅黑;"><span style="font-size: 17px;">弱视是儿童常见的视觉发育障碍之一,作为儿童视力丧失的常见原因之一,困扰着无数家庭和医疗工作者。传统治疗金标准</span></span><span style="font-family: 微软雅黑;"><span style="font-size: 17px;">&ldquo;遮盖疗法&rdquo;,通常通过遮挡健眼来促进弱视眼的视觉发展。然而,遮盖疗法的依从性差,且对患者的日常生活有一定影响,这两点难题始终未得到有效解决。近年来,双眼追踪数字疗法作为一种新兴的治疗方法,通过对非弱视眼实施视觉模糊处理,避免了遮盖治疗的局限性。</span></span></span></p><p>&nbsp;</p><p><span style="mso-spacerun: yes; font-family: 微软雅黑; font-size: 10.5000pt; mso-font-kerning: 0.0000pt;"><span style="font-family: 微软雅黑;">&nbsp;</span></span></p></section></section></section></section></section><section style="margin: 0px 0px 10px; box-sizing: border-box;"><section style="font-size: 14px; color: #375eb5; letter-spacing: 1px; box-sizing: border-box;"><p style="margin: 0px; padding: 0px; box-sizing: border-box;"><strong style="box-sizing: border-box;">CureSight</strong></p></section><section style="display: inline-block; vertical-align: top; width: auto; align-self: flex-start; flex: 0 0 auto; background-color: #375eb5; min-width: 5%; max-width: 100%; height: auto; border-left: 2px solid #ffffff; border-right: 2px solid #ffffff; border-bottom-right-radius: 10px; overflow: hidden; box-sizing: border-box;"><section style="margin: 3px 0px; box-sizing: border-box;"><section style="text-align: justify; font-size: 14px; color: #f4d997; padding: 0px 20px; letter-spacing: 1px; box-sizing: border-box;"><p style="white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;"><strong style="box-sizing: border-box;">引领弱视治疗新方法</strong></p></section></section></section></section></section></section></section></section><p style="white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;">&nbsp;</p><section style="text-align: center; justify-content: center; display: flex; flex-flow: row; margin: 0px 0px 10px; box-sizing: border-box;"><section style="display: inline-block; width: 90%; vertical-align: top; align-self: flex-start; flex: 0 0 auto; border-style: solid; border-width: 3px 1px; border-color: #375eb5; height: auto; background-color: #ffffff; box-sizing: border-box;"><section style="margin: 20px 0px; box-sizing: border-box;"><section style="text-align: justify; line-height: 1.7; letter-spacing: 1px; padding: 0px 20px; box-sizing: border-box;"><p style="white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;">2019年:以色列和中国开展预研究,证实<strong style="box-sizing: border-box;">CureSight可有效提升弱视患者视力和立体视。</strong></p><p style="white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;">2020年8月:启动<span style="color: #15b3ad; box-sizing: border-box;"><strong style="box-sizing: border-box;">全球首个与&ldquo;金标准&rdquo;遮盖治疗对照</strong></span>的多中心、随机、盲法、大规模临床试验研究,验证CureSight对4-9岁弱视患者的安全性和有效性。</p><p style="white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;">2021年9月:该RCT研究在<span style="color: #15b3ad; box-sizing: border-box;"><strong style="box-sizing: border-box;">美国和中国</strong></span>启动,对不同种族弱视患者有效性进行全面评估。</p></section></section></section></section><section style="margin: 20px 0px 0px; box-sizing: border-box;"><section style="color: #375eb5; box-sizing: border-box;"><p style="text-align: center; white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;"><strong style="box-sizing: border-box;">PART.1</strong></p></section></section><section style="text-align: center; justify-content: center; display: flex; flex-flow: row; margin: 0px 0px 20px; box-sizing: border-box;"><section style="display: inline-block; vertical-align: middle; width: auto; align-self: center; flex: 0 0 auto; min-width: 5%; max-width: 100%; height: auto; box-sizing: border-box;"><section style="margin: 10px 0px 0px; box-sizing: border-box;"><section style="display: inline-block; width: 10px; height: 10px; vertical-align: top; overflow: hidden; background-color: #375eb5; border-radius: 100%; box-sizing: border-box;"></section></section></section><section style="display: inline-block; vertical-align: middle; width: auto; align-self: center; flex: 0 0 auto; min-width: 5%; max-width: 100%; height: auto; border-style: double; border-width: 2px 0px; border-top-color: #375eb5; border-bottom-color: #375eb5; box-sizing: border-box;"><section style="text-align: justify; color: #375eb5; padding: 0px 10px; letter-spacing: 1px; box-sizing: border-box;"><p style="white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;"><strong style="box-sizing: border-box;">CureSight的坚实医学循证</strong></p></section></section><section style="display: inline-block; vertical-align: middle; width: auto; align-self: center; flex: 0 0 auto; min-width: 5%; max-width: 100%; height: auto; box-sizing: border-box;"><section style="margin: 10px 0px 0px; box-sizing: border-box;"><section style="display: inline-block; width: 10px; height: 10px; vertical-align: top; overflow: hidden; background-color: #375eb5; border-radius: 100%; box-sizing: border-box;"></section></section></section></section><section style="text-align: center; justify-content: center; display: flex; flex-flow: row; box-sizing: border-box;"><section style="display: inline-block; width: 90%; vertical-align: top; align-self: flex-start; flex: 0 0 auto; height: auto; background-color: #ffffff; padding: 20px; box-sizing: border-box; border: 1px solid #375eb5;"><section style="margin: 0px 0px 20px; box-sizing: border-box;"><section style="text-align: justify; color: #3e3e3e; letter-spacing: 1px; line-height: 1.7; box-sizing: border-box;"><p><span style="mso-spacerun: yes; font-family: 微软雅黑; font-size: 10.5000pt; mso-font-kerning: 0.0000pt;"><span style="font-family: 微软雅黑;"><span style="font-size: 17px;">2022年10月,双眼追踪数字疗法</span></span></span><span style="mso-spacerun: yes; font-family: 微软雅黑; font-size: 12.0000pt;"><span style="font-family: 微软雅黑;"><span style="font-size: 17px;">CureSight</span></span></span><span style="mso-spacerun: yes; font-family: 微软雅黑; font-size: 12.0000pt; mso-font-kerning: 0.0000pt;"><span style="font-family: 微软雅黑;"><span style="font-size: 17px;">非劣效于</span></span><span style="font-family: 微软雅黑;"><span style="font-size: 17px;">&ldquo;金标准&rdquo;的关键研究结果在眼科顶刊《Ophthalmology》上震撼发表),打破了弱视治疗领域数字疗法无法与金标准媲美的长期印象。基于此重大研究成果</span>,</span></span><span style="color: #15b3ad; box-sizing: border-box;"><strong style="box-sizing: border-box;">AAO 弱视治疗指南PPP</strong></span>(Amblyopia Preferred Practice Pattern American Academy of Ophthalmology)在仅仅时隔2年,于 2024年2月对其 2022年9月修订的南再度进行更新。<strong style="box-sizing: border-box;"><span style="color: #15b3ad; box-sizing: border-box;">此次更新中,删除了双眼数字疗法缺少临床验证的描述,并将 CureSight 治疗方法纳入指南参考,</span></strong>这一重大举措充分体现了指南的与时俱进以及对新技术的高度认可,更标志着弱视治疗领域的重大突破。</p></section></section><section style="display: flex; width: 100%; flex-flow: column; box-sizing: border-box;"><section style="z-index: 2; box-sizing: border-box;"><section style="display: flex; width: 100%; flex-flow: column; box-sizing: border-box;"><section style="z-index: 1; box-sizing: border-box;"><section style="display: flex; width: 100%; flex-flow: column; box-sizing: border-box;"></section></section></section></section></section><section style="justify-content: center; display: flex; flex-flow: row; margin: 10px 0px; box-sizing: border-box;"><section style="display: inline-block; width: 100%; vertical-align: top; align-self: flex-start; flex: 0 0 auto; height: auto; background-color: #feffff; padding: 5px; box-sizing: border-box; border: 1px solid #89ab7f;"><section style="text-align: left; justify-content: flex-start; display: flex; flex-flow: row; box-sizing: border-box;"><section style="display: inline-block; vertical-align: top; width: 50%; align-self: flex-start; flex: 0 0 auto; line-height: 0; box-sizing: border-box;"><section style="box-sizing: border-box;"><section style="display: inline-block; width: 15px; height: 15px; vertical-align: top; overflow: hidden; border-left: 1px solid #89ab7f; border-top: 1px solid #89ab7f; padding: 2px; line-height: 0; box-sizing: border-box;"></section></section></section><section style="display: inline-block; vertical-align: top; width: 50%; align-self: flex-start; flex: 0 0 auto; line-height: 0; box-sizing: border-box;"><section style="transform: perspective(0px); -webkit-transform: perspective(0px); -moz-transform: perspective(0px); -o-transform: perspective(0px); transform-style: flat; box-sizing: border-box;"><section style="transform: rotateY(180deg); -webkit-transform: rotateY(180deg); -moz-transform: rotateY(180deg); -o-transform: rotateY(180deg); box-sizing: border-box;"><section style="display: inline-block; width: 15px; height: 15px; vertical-align: top; overflow: hidden; border-left: 1px solid #89ab7f; border-top: 1px solid #89ab7f; padding: 2px; line-height: 0; box-sizing: border-box;"></section></section></section></section></section><section style="text-align: left; justify-content: flex-start; display: flex; flex-flow: row; box-sizing: border-box;"><section style="display: inline-block; width: 100%; vertical-align: top; align-self: flex-start; flex: 0 0 auto; padding: 5px 20px; box-sizing: border-box;"><section style="margin: 0px 0px 5px; box-sizing: border-box;"><section style="display: inline-block; width: 100%; vertical-align: top; overflow: hidden; align-self: flex-start; line-height: 0; box-sizing: border-box;"></section></section></section></section><section style="transform: perspective(0px); -webkit-transform: perspective(0px); -moz-transform: perspective(0px); -o-transform: perspective(0px); transform-style: flat; box-sizing: border-box;"><section style="text-align: left; justify-content: flex-start; display: flex; flex-flow: row; transform: rotateX(180deg); -webkit-transform: rotateX(180deg); -moz-transform: rotateX(180deg); -o-transform: rotateX(180deg); box-sizing: border-box;"><section style="display: inline-block; vertical-align: top; width: 50%; align-self: flex-start; flex: 0 0 auto; line-height: 0; box-sizing: border-box;"><section style="box-sizing: border-box;"><section style="display: inline-block; width: 15px; height: 15px; vertical-align: top; overflow: hidden; border-left: 1px solid #89ab7f; border-top: 1px solid #89ab7f; padding: 2px; line-height: 0; box-sizing: border-box;"></section></section></section><section style="display: inline-block; vertical-align: top; width: 50%; align-self: flex-start; flex: 0 0 auto; line-height: 0; box-sizing: border-box;"><section style="transform: perspective(0px); -webkit-transform: perspective(0px); -moz-transform: perspective(0px); -o-transform: perspective(0px); transform-style: flat; box-sizing: border-box;"><section style="transform: rotateY(180deg); -webkit-transform: rotateY(180deg); -moz-transform: rotateY(180deg); -o-transform: rotateY(180deg); box-sizing: border-box;"><section style="display: inline-block; width: 15px; height: 15px; vertical-align: top; overflow: hidden; border-left: 1px solid #89ab7f; border-top: 1px solid #89ab7f; padding: 2px; line-height: 0; box-sizing: border-box;"></section></section></section></section></section></section></section></section><section style="margin: 0px 0px 20px; box-sizing: border-box;"><section style="text-align: justify; font-size: 14px; color: #3e3e3e; letter-spacing: 1px; line-height: 1.7; box-sizing: border-box;"><p style="text-indent: 2em; white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;"><span style="font-size: 16px; box-sizing: border-box;">2024年2月,CureSight 长期有效性在AJO发表。其随访结果表明<strong style="box-sizing: border-box;"><span style="color: #15b3ad; box-sizing: border-box;">&ldquo;CureSight 单独治疗后的视力与立体视获益在 1 年内保持稳固,且相比传统标准疗法,回退率更低)<sup style="box-sizing: border-box;"></sup>&rdquo;。</span></strong>今年8月,以色列联合美国的CureSight研究结果, 再度发表于AJO,符合方案数据(PP)集的临床结果显示,<span style="color: #15b3ad; box-sizing: border-box;"><strong style="box-sizing: border-box;">CureSight 治疗组在第 16 周时,相较基线的视力平均改善显著优于遮盖组。</strong></span>两组较基线的 LS 均值差异为 0.05 logMAR(95% 置信区间为 0.007至0.097), 具有显著统计学意义<sup style="box-sizing: border-box;"></sup>。</span></p></section></section><section style="line-height: 0; box-sizing: border-box;"><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"><img class="rich_pages wxw-img" style="vertical-align: middle; max-width: 100%; width: 567.297px !important; box-sizing: border-box; height: auto !important; visibility: visible !important;" src="https://pic.app.fy169.net/Fg8SQcpKc2bLVOD9jWFkK8nUltbg" alt="图片" /></section></section><p style="margin: 0px; padding: 0px; box-sizing: border-box;"><strong style="box-sizing: border-box;">&nbsp;</strong></p><section style="margin: 0px; box-sizing: border-box;"><section style="background-color: #375eb5; height: 2px; box-sizing: border-box;"></section></section></section></section><section style="margin: 20px 0px 0px; box-sizing: border-box;"><section style="color: #375eb5; box-sizing: border-box;"><p style="text-align: center; white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;"><strong style="box-sizing: border-box;">PART.2</strong></p></section></section><section style="text-align: center; justify-content: center; display: flex; flex-flow: row; margin: 0px 0px 20px; box-sizing: border-box;"><section style="display: inline-block; vertical-align: middle; width: auto; align-self: center; flex: 0 0 auto; min-width: 5%; max-width: 100%; height: auto; box-sizing: border-box;"><section style="margin: 10px 0px 0px; box-sizing: border-box;"><section style="display: inline-block; width: 10px; height: 10px; vertical-align: top; overflow: hidden; background-color: #375eb5; border-radius: 100%; box-sizing: border-box;"></section></section></section><section style="display: inline-block; vertical-align: middle; width: auto; align-self: center; flex: 0 0 auto; min-width: 5%; max-width: 100%; height: auto; border-style: double; border-width: 2px 0px; border-top-color: #375eb5; border-bottom-color: #375eb5; box-sizing: border-box;"><section style="text-align: justify; color: #375eb5; padding: 0px 10px; letter-spacing: 1px; box-sizing: border-box;"><p style="white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;"><strong style="box-sizing: border-box;">CureSight视觉训练设备</strong></p></section></section><section style="display: inline-block; vertical-align: middle; width: auto; align-self: center; flex: 0 0 auto; min-width: 5%; max-width: 100%; height: auto; box-sizing: border-box;"><section style="margin: 10px 0px 0px; box-sizing: border-box;"><section style="display: inline-block; width: 10px; height: 10px; vertical-align: top; overflow: hidden; background-color: #375eb5; border-radius: 100%; box-sizing: border-box;"></section></section></section></section><section style="text-align: center; justify-content: center; display: flex; flex-flow: row; box-sizing: border-box;"><section style="display: inline-block; width: 90%; vertical-align: top; align-self: flex-start; flex: 0 0 auto; height: auto; background-color: #ffffff; padding: 20px; box-sizing: border-box; border: 1px solid #375eb5;"><section style="margin: 0px 0px 20px; box-sizing: border-box;"><section style="text-align: justify; font-size: 14px; color: #3e3e3e; letter-spacing: 1px; line-height: 1.7; box-sizing: border-box;"><p><span style="mso-spacerun: yes; font-family: 微软雅黑; font-size: 10.5000pt; mso-font-kerning: 0.0000pt;"><span style="font-family: 微软雅黑;"><span style="font-size: 17px;">双眼追踪数字疗法</span></span></span><span style="mso-spacerun: yes; font-family: 微软雅黑; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 微软雅黑;"><span style="font-size: 17px;">CureSight是一款基于眼动追踪的数字化弱视治疗系统,患者配戴红蓝治疗眼镜后,在线观看任意视频内容,即可进行弱视治疗。不同于现有的治疗技术,CureSight通过独家算法和眼动追踪技术,可以进行实时图像处理,模糊处理非弱视眼视觉中心的图像,保持周边清晰,同时在弱视眼呈现清晰的图像,训练双眼一起工作。这种治疗方式可在提升弱视眼视力的同时,也能改善双眼视觉功能。同时,该方法极大地提高了患者的治疗体验和依从性。</span></span></span></p><p>&nbsp;</p><section></section><p style="text-indent: 2.1429em; white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;"><em style="box-sizing: border-box;"><span style="font-size: 16px; color: #000000; text-decoration: none; box-sizing: border-box;">&nbsp;</span></em></p><section></section><p style="text-indent: 0em; white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;">&nbsp;</p></section></section><section style="margin: 8px 0px 2px; box-sizing: border-box;"><section style="background-color: #375eb5; height: 2px; box-sizing: border-box;"></section></section><section style="text-align: left; justify-content: flex-start; display: flex; flex-flow: row; margin: 0px 0px 20px; box-sizing: border-box;"><section style="display: inline-block; width: auto; vertical-align: top; align-self: flex-start; flex: 0 0 auto; background-color: #375eb5; min-width: 5%; max-width: 100%; height: auto; box-sizing: border-box;"><section style="text-align: justify; color: #f4d997; padding: 0px 10px; box-sizing: border-box;"><p style="white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;"><strong style="box-sizing: border-box;">CureSight已获得CE和FDA 批准</strong></p></section></section></section><section style="text-align: justify; line-height: 1.7; letter-spacing: 1px; box-sizing: border-box;"><p style="text-indent: 2.125em; white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;">CureSight已获得CE和FDA 批准,在美国商业化方面,<span style="color: #15b3ad; box-sizing: border-box;"><strong style="box-sizing: border-box;">首创性</strong></span>的获得美国医学学会(AMA)授予的<span style="color: #15b3ad; box-sizing: border-box;"><strong style="box-sizing: border-box;">3项CPT代码</strong></span>,实现了保险支付的覆盖。美国上市1年多,已覆盖全美41个州,超过20%的儿童眼科医生市场。获得了美国一线小儿眼科医生的高度赞誉和患者喜爱。梅奥医学中心,麻省总医院,克利夫兰医学中心,约翰霍普金斯等美国Top医院均将CureSight应用于临床治疗中。</p></section><section style="line-height: 0; box-sizing: border-box;"><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"><img class="rich_pages wxw-img" style="vertical-align: middle; max-width: 100%; width: 567.297px !important; box-sizing: border-box; height: auto !important; visibility: visible !important;" src="https://pic.app.fy169.net/Fq5YQi5UicFOT5pIGPa6o6MCwHdd" alt="图片" /></section><p>&nbsp;</p></section><section style="line-height: 0; box-sizing: border-box;"><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"></section></section><section style="line-height: 0; box-sizing: border-box;"><section class="channels_iframe_wrp"></section><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"></section></section><section style="line-height: 0; box-sizing: border-box;"><section></section><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"></section></section><section style="line-height: 0; box-sizing: border-box;"><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"></section></section><section style="line-height: 0; box-sizing: border-box;"><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"></section><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"></section><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"></section><section style="max-width: 100%; vertical-align: middle; line-height: 0; box-sizing: border-box;"></section></section></section></section><p style="white-space: normal; margin: 0px; padding: 0px; box-sizing: border-box;">&nbsp;</p><p style="display: none;">&nbsp;</p>    <!----></div>            

徽太郎 发表于 2025-6-17 05:57

支持支持

玩的开心 发表于 2025-6-17 07:24

{:6_315:}

玩的开心 发表于 2025-6-17 07:24

{:6_315:}{:6_315:}

玩的开心 发表于 2025-6-17 07:24

{:6_315:}{:6_315:}{:6_315:}
页: [1]
查看完整版本: 重磅 弱视双眼追踪数字疗法!

Powered by Discuz! X3.4 Archiver   © 2001-2023 Discuz! Team.